← hubDrugs

3 sources

← All substances
🔗 MergedComparePsychonautWikiTripSitPharmacology
Sections

🧬 Receptor activity

TargetActionAffinitySource
5-hydroxytryptamine receptor 2BKi 4.6 nMCHEMBL
5-hydroxytryptamine receptor 1DKi 19 nMCHEMBL
D(1A) dopamine receptorKi 20 nMCHEMBL
5-hydroxytryptamine receptor 2AKi 25 nMCHEMBL
5-hydroxytryptamine receptor 1EKi 44 nMCHEMBL
5-hydroxytryptamine receptor 1AKi 63 nMCHEMBL
5-hydroxytryptamine receptor 5AKi 70 nMCHEMBL
5-hydroxytryptamine receptor 6Ki 72 nMCHEMBL
5-hydroxytryptamine receptor 7Ki 72 nMCHEMBL
D(3) dopamine receptorKi 100 nMCHEMBL
5-hydroxytryptamine receptor 2CKi 140 nMCHEMBL
5-hydroxytryptamine receptor 1BKi 305 nMCHEMBL
Adenosine receptor A2bKi 1300 nMCHEMBL
Adenosine receptor A2aKi 2000 nMCHEMBL
D(1B) dopamine receptorKi 10000 nMCHEMBL
D(2) dopamine receptorKi 10000 nMCHEMBL
Adenosine receptor A1Ki 10000 nMCHEMBL
D(4) dopamine receptorKi 10000 nMCHEMBL
UncheckedKi 10000 nMCHEMBL
‹ PrevPage 1 / 11–19 of 19Next ›

Pharmacokinetics

Metabolism

Psilocin has known human metabolites that include (2S,3S,4S,5R)-6-[[3-[2-(dimethylamino)ethyl]-1H-indol-4-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid.

Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.